De-Risk Health Tech Investments

De-risk your health tech investments with ActiVie’s strategic clinical and regulatory support.

Health tech startups often face significant hurdles in clinical research and regulatory approvals. For investor groups ensuring portfolio companies meet these milestones is crucial to their success. ActiVie offers fractional scientific and operational expertise that supports your portfolio companies in navigating clinical trials, regulatory submissions, and time-to-market challenges.

Proven Solutions

We provide tailored clinical research and regulatory expertise for your portfolio companies, from trial design to market access pathway. Our fractional model allows you to provide your startups with expert support without the need for full-time hires.

ActiVie’s team helps your portfolio companies navigate complex clinical trials and regulatory approval processes, ensuring they meet critical development milestones on time and within budget.

We offer strategic guidance across R&D, regulatory compliance, and market access strategies, helping your portfolio companies align their development plans with market opportunities and secure additional funding.

Looking to de-risk your health tech investments? Contact us today to see how ActiVie’s fractional support can help your portfolio companies thrive.